Additionally, a study on nanoengineering an MFO for osteosarcoma chemo-immunotherapy shows how modulation of IDO and MDSCs can enhance the effectiveness of chemo-immunotherapy [25]. This evidence concerns the gene IDO1 and osteosarcoma.